Intermittent claudication – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Wed, 24 Jun 2026 04:15:10 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Intermittent claudication – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on Low-Dose Colchicine for Patients with Peripheral Artery Disease to Reduce Cardiovascular Risks https://clinicaltrials.eu/trial/study-on-low-dose-colchicine-for-patients-with-peripheral-artery-disease-to-reduce-cardiovascular-risks/ Wed, 29 Apr 2026 15:03:16 +0000 https://clinicaltrials.eu/trial/study-on-low-dose-colchicine-for-patients-with-peripheral-artery-disease-to-reduce-cardiovascular-risks/ This clinical trial is focused on studying the effects of a medication called Colchicine in patients with Peripheral Artery Disease (PAD). Peripheral Artery Disease is a condition where the blood vessels outside the heart and brain become narrowed, often leading to reduced blood flow to the limbs. The study will use Colchicine Tiofarma 500 microgram Tablets, which is a low-dose form of the medication, to see if it can help reduce the risk of serious heart and blood vessel problems in people with this condition.

The purpose of the study is to examine how effective and safe Colchicine is in lowering the chances of events like heart attacks, strokes, or severe issues with blood flow to the limbs that might require medical procedures or even amputation. Participants in the study will either receive the Colchicine tablets or a placebo, which looks like the medication but does not contain the active ingredient. The study will last for a period of time, during which participants will take the tablets daily and be monitored for any changes in their health.

Throughout the study, researchers will keep track of various health outcomes, such as the occurrence of heart-related events, hospitalizations, and any need for medical procedures to improve blood flow. The goal is to determine if taking Colchicine can help improve the quality of life and reduce the risk of serious complications for people living with Peripheral Artery Disease.

]]>